Keyphrases
Pediatric Hematopoietic Stem Cell Transplantation
100%
Cyclosporine
100%
Tacrolimus
100%
Thalassemia
100%
Graft-versus-host Disease (GvHD)
87%
Calcineurin Inhibitors
37%
Nephrotoxicity
37%
No Significant Difference
25%
Neurotoxicity
25%
Graft-versus-host Disease Prophylaxis
25%
Adverse Effects
12%
Clinical Situation
12%
Engraftment Syndrome
12%
Retrospective Analysis
12%
Antalya
12%
Pediatric Patients
12%
Liver Graft
12%
January 2017
12%
Disease Stage
12%
Venous Disease
12%
Allogeneic HSCT
12%
Pediatric HSCT
12%
CMV Reactivation
12%
Effective Prevention
12%
Disease Occurrence
12%
Graft Rejection
12%
Medicine and Dentistry
Hematopoietic Stem Cell Transplantation
100%
Cyclosporine
100%
Thalassemia
100%
Tacrolimus
100%
Graft Versus Host Reaction
87%
Calcineurin Inhibitor
37%
Nephrotoxicity
37%
Prophylaxis
25%
Acute Graft Versus Host Disease
25%
Gut
25%
Neurotoxicity
25%
Adverse Event
12%
Allogeneic Hematopoietic Stem Cell Transplantation
12%
Spine
12%
Engraftment Syndrome
12%
Liver Graft
12%
Pediatrics Patient
12%
Vein Occlusion
12%
Graft Rejection
12%
Pharmacology, Toxicology and Pharmaceutical Science
Ciclosporin
100%
Tacrolimus
100%
Thalassemia
100%
Graft Versus Host Reaction
87%
Nephrotoxicity
37%
Calcineurin Inhibitor
37%
Neurotoxicity
25%
Acute Graft Versus Host Disease
25%
Adverse Event
12%
Engraftment Syndrome
12%
Vein Occlusion
12%
Graft Rejection
12%